Lisanti Capital Growth LLC Takes $1.79 Million Position in Evolent Health, Inc. (NYSE:EVH)

Lisanti Capital Growth LLC acquired a new position in Evolent Health, Inc. (NYSE:EVH - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 54,190 shares of the technology company's stock, valued at approximately $1,790,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Bank of New York Mellon Corp lifted its position in shares of Evolent Health by 8.7% during the third quarter. Bank of New York Mellon Corp now owns 1,655,609 shares of the technology company's stock worth $45,082,000 after acquiring an additional 133,038 shares in the last quarter. Brown Advisory Inc. lifted its holdings in Evolent Health by 17.8% during the 3rd quarter. Brown Advisory Inc. now owns 36,870 shares of the technology company's stock worth $1,004,000 after purchasing an additional 5,564 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Evolent Health by 20.5% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 20,678 shares of the technology company's stock worth $563,000 after purchasing an additional 3,514 shares during the period. Summit Creek Advisors LLC boosted its stake in Evolent Health by 0.4% in the 3rd quarter. Summit Creek Advisors LLC now owns 559,495 shares of the technology company's stock worth $15,235,000 after purchasing an additional 2,425 shares during the period. Finally, Teacher Retirement System of Texas grew its holdings in Evolent Health by 9.0% during the 3rd quarter. Teacher Retirement System of Texas now owns 8,293 shares of the technology company's stock valued at $226,000 after buying an additional 685 shares in the last quarter.

Evolent Health Stock Up 1.4 %

Shares of EVH stock traded up $0.38 on Tuesday, hitting $27.62. 1,398,399 shares of the company's stock traded hands, compared to its average volume of 943,595. The company's fifty day simple moving average is $31.28 and its 200 day simple moving average is $30.28. Evolent Health, Inc. has a one year low of $23.33 and a one year high of $35.83. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.01 and a quick ratio of 1.01.

Evolent Health (NYSE:EVH - Get Free Report) last released its quarterly earnings data on Thursday, February 22nd. The technology company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.02 by $0.13. Evolent Health had a positive return on equity of 6.60% and a negative net margin of 5.76%. The firm had revenue of $556.06 million for the quarter, compared to the consensus estimate of $541.87 million. On average, sell-side analysts forecast that Evolent Health, Inc. will post 0.87 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on EVH shares. Citigroup began coverage on shares of Evolent Health in a research report on Monday, April 22nd. They issued a "buy" rating and a $40.00 price objective for the company. JMP Securities boosted their price target on shares of Evolent Health from $37.00 to $38.00 and gave the company a "market outperform" rating in a research report on Friday, February 23rd. Oppenheimer initiated coverage on Evolent Health in a research report on Friday, March 1st. They issued an "outperform" rating and a $45.00 price objective on the stock. Canaccord Genuity Group reduced their target price on Evolent Health from $45.00 to $44.00 and set a "buy" rating for the company in a research report on Thursday, March 28th. Finally, William Blair restated an "outperform" rating on shares of Evolent Health in a research note on Tuesday, January 9th. One analyst has rated the stock with a sell rating, one has given a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat.com, Evolent Health has a consensus rating of "Moderate Buy" and an average price target of $42.70.

Evolent Health Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.